Medicinal Products

Zilart 250 mg tablete za oralnu suspenziju

Name Zilart 250 mg tablete za oralnu suspenziju
Marketing Authorisation Number HR-H-379666860
Active Substance deferasiroxum
Pharmaceutical Form tableta za oralnu suspenziju
Strength 250 mg
Packaging [MA Number for Packaging] 28 tableta u blisteru, u kutiji  [HR-H-379666860-01]
84 tablete u blisteru, u kutiji  [HR-H-379666860-02]
252 tablete u blisteru, u kutiji  [HR-H-379666860-03]
Manufacturer Pharmascience International Limited, Nicosia, Cipar
Marketing Authorisation Holder Makpharm d.o.o., Folnegovićeva 1/A, Zagreb
Marketing Authorisation Date 16.05.2018
MA Period of Validity 16.05.2023
Classification Number UP/I-530-09/17-01/153
Registration Number 381-12-01/30-18-08
Composition svaka tableta za oralnu suspenziju sadrži 250 mg deferasiroksa
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code V03AC03
Medicinal product marketed in the Croatia Ne
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Brošura za zdravstvene radnike, verzija 1
Educational materials
for patients / caregivers
Brošura za bolesnike, verzija 1
Back